Cargando…
Intratumoral cancer immunotherapy exploiting anti-viral immunity
After a long period of endeavor, immunotherapy has become the mainstream of cancer therapies. This success is mostly ascribed to immune checkpoint blockade, chimeric antigen receptor-transduced T cell therapies, and bispecific antibodies. However, these methods have been effective or applicable to o...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
JSLRT
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010499/ https://www.ncbi.nlm.nih.gov/pubmed/34707035 http://dx.doi.org/10.3960/jslrt.21023 |